Evaluation of Safety and Efficacy of Glaritus<sup>®</sup> versus Lantus<sup>®</sup> in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study

ISSN Print: 2165-7424
ISSN Online: 2165-7432
www.scirp.net/journal/ojemd
E-mail: [email protected]

Citations

"Evaluation of Safety and Efficacy of Glaritus^® versus Lantus^® in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study"
written by Gaurav Puppalwar, Sandesh Sawant, Bhimsen Silgiri, Kirti Shukla, Hanmant Barkate,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.7 No.4, 2017

has been cited by the following article(s):

[1]	Future Prospects of Insulin Mutants, Biosimilars, Bioconjugates, and Newer Insulin-delivery Devices in Diabetes Mellitus
	Journal of Exploratory …, 2023

[2]	Measurement of Glycated Hemoglobin and Levels of Depression in Diabetic Patients in Kirkuk City, Iraq
	2021

[3]	Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized …
	Acta Diabetologica, 2018

[4]	Immunogenicity, Safety and Efficacy Comparison of Wockhardt's Biosimilar Insulin Glargine—GlaritusŽ with Reference Product—LantusŽ: Study Protocol & …
	2018

[5]	Immunogenicity, Safety and Efficacy Comparison of Wockhardt's Biosimilar Insulin Glargine—Glaritus® with Reference Product—Lantus®: Study Protocol & …
	2018

[1]	The Adjunctive Role of Antimicrobial Photodynamic Therapy to Non-Surgical Treatment in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Healthcare, 2025 DOI:10.3390/healthcare13141703

[2]	Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends Open Journal of Endocrine and Metabolic Diseases, 2018 DOI:10.4236/ojemd.2018.88016

[3]	Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized clamp study Acta Diabetologica, 2018 DOI:10.1007/s00592-018-1113-3